Publications found:
55,654
Sort by:
Endometriosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENDOMETRIOSIS PIPELINE REPORT INCLUDES Panorama of Endometriosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
110 pages
Enterocolitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ENTEROCOLITIS PIPELINE REPORT INCLUDES Panorama of Enterocolitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Eosinophilic Esophagitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EOSINOPHILIC ESOPHAGITIS PIPELINE REPORT INCLUDES Panorama of Eosinophilic Esophagitis pipeline markets including statistics on therapeutic drugs and companies involved Eosinophilic Esophagitis Pipeline candidates across various development ...
August 2018
50 pages
Ependymoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF EPENDYMOMA PIPELINE REPORT INCLUDES Panorama of Ependymoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Epidermolysis Bullosa R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EPIDERMOLYSIS BULLOSA PIPELINE REPORT INCLUDES Panorama of Epidermolysis Bullosa pipeline markets including statistics on therapeutic drugs and companies involved Epidermolysis Bullosa Pipeline candidates across various development ...
August 2018
90 pages
Epstein Barr Viral Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF EPSTEIN BARR VIRAL INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein Barr Viral Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein Barr Viral Infections Pipeline candidates across ...
August 2018
140 pages
Epstein–Barr Virus (HHV 4) Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV 4) INFECTIONS PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV 4) Infections pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV 4) Infections Pipeline candidates across ...
August 2018
140 pages
Equine Encephalitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Equine Encephalitis Pipeline candidates across various development ...
August 2018
40 pages
Erectile Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ERECTILE DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Erectile Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Erectile Dysfunction Pipeline candidates across various development ...
August 2018
90 pages
Escherichia coli Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ESCHERICHIA COLI INFECTIONS PIPELINE REPORT INCLUDES Panorama of Escherichia coli Infections pipeline markets including statistics on therapeutic drugs and companies involved Escherichia coli Infections Pipeline candidates across various development ...
August 2018
150 pages
Essential Thrombocythemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ESSENTIAL THROMBOCYTHEMIA PIPELINE REPORT INCLUDES Panorama of Essential Thrombocythemia pipeline markets including statistics on therapeutic drugs and companies involved Essential Thrombocythemia Pipeline candidates across various development ...
August 2018
70 pages
Essential Tremor R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ESSENTIAL TREMOR PIPELINE REPORT INCLUDES Panorama of Essential Tremor pipeline markets including statistics on therapeutic drugs and companies involved Essential Tremor Pipeline candidates across various development ...
August 2018
40 pages
Exocrine Pancreatic Insufficiency R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF EXOCRINE PANCREATIC INSUFFICIENCY PIPELINE REPORT INCLUDES Panorama of Exocrine Pancreatic Insufficiency pipeline markets including statistics on therapeutic drugs and companies involved Exocrine Pancreatic Insufficiency Pipeline candidates across various development ...
August 2018
40 pages
Fabry Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FABRY DISEASE PIPELINE REPORT INCLUDES Panorama of Fabry Disease pipeline markets including statistics on therapeutic drugs and companies involved Fabry Disease Pipeline candidates across various development ...
August 2018
70 pages
Familial Adenomatous Polyposis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FAMILIAL ADENOMATOUS POLYPOSIS PIPELINE REPORT INCLUDES Panorama of Familial Adenomatous Polyposis pipeline markets including statistics on therapeutic drugs and companies involved Familial Adenomatous Polyposis Pipeline candidates across various development ...
August 2018
30 pages
Familial Amyloid Neuropathies R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FAMILIAL AMYLOID NEUROPATHIES PIPELINE REPORT INCLUDES Panorama of Familial Amyloid Neuropathies pipeline markets including statistics on therapeutic drugs and companies involved Familial Amyloid Neuropathies Pipeline candidates across various development ...
August 2018
60 pages
Fanconi Anemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FANCONI ANEMIA PIPELINE REPORT INCLUDES Panorama of Fanconi Anemia pipeline markets including statistics on therapeutic drugs and companies involved Fanconi Anemia Pipeline candidates across various development ...
August 2018
40 pages
Fatigue R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF FATIGUE PIPELINE REPORT INCLUDES Panorama of Fatigue pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Female Contraception R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FEMALE CONTRACEPTION PIPELINE REPORT INCLUDES Panorama of Female Contraception pipeline markets including statistics on therapeutic drugs and companies involved Female Contraception Pipeline candidates across various development ...
August 2018
70 pages
Female Hypoactive Sexual Desire Disorder R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER PIPELINE REPORT INCLUDES Panorama of Female Hypoactive Sexual Desire Disorder pipeline markets including statistics on therapeutic drugs and companies involved Female Hypoactive Sexual Desire Disorder Pipeline candidates across ...
August 2018
40 pages
Female Sexual Dysfunction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FEMALE SEXUAL DYSFUNCTION PIPELINE REPORT INCLUDES Panorama of Female Sexual Dysfunction pipeline markets including statistics on therapeutic drugs and companies involved Female Sexual Dysfunction Pipeline candidates across various development ...
August 2018
50 pages
Fibrinogen Deficiency (Factor I Deficiency) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF FIBRINOGEN DEFICIENCY (FACTOR I DEFICIENCY) PIPELINE REPORT INCLUDES Panorama of Fibrinogen Deficiency (Factor I Deficiency) pipeline markets including statistics on therapeutic drugs and companies involved Fibrinogen Deficiency (Factor I Deficiency) Pipeline candidates across ...
August 2018
30 pages
Fibrodysplasia Ossificans Progressiva R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA PIPELINE REPORT INCLUDES Panorama of Fibrodysplasia Ossificans Progressiva pipeline markets including statistics on therapeutic drugs and companies involved Fibrodysplasia Ossificans Progressiva Pipeline candidates across various development ...
August 2018
50 pages
Fibromyalgia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROMYALGIA PIPELINE REPORT INCLUDES Panorama of Fibromyalgia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Fibrosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROSARCOMA PIPELINE REPORT INCLUDES Panorama of Fibrosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
Fibrosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF FIBROSIS PIPELINE REPORT INCLUDES Panorama of Fibrosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
100 pages
Focal Segmental Glomerulosclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS PIPELINE REPORT INCLUDES Panorama of Focal Segmental Glomerulosclerosis pipeline markets including statistics on therapeutic drugs and companies involved Focal Segmental Glomerulosclerosis Pipeline candidates across various development ...
August 2018
50 pages
Fragile X Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FRAGILE X SYNDROME PIPELINE REPORT INCLUDES Panorama of Fragile X Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Fragile X Syndrome Pipeline candidates across various development ...
August 2018
110 pages
Friedreich Ataxia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FRIEDREICH ATAXIA PIPELINE REPORT INCLUDES Panorama of Friedreich Ataxia pipeline markets including statistics on therapeutic drugs and companies involved Friedreich Ataxia Pipeline candidates across various development ...
August 2018
70 pages
Functional Dyspepsia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF FUNCTIONAL DYSPEPSIA PIPELINE REPORT INCLUDES Panorama of Functional Dyspepsia pipeline markets including statistics on therapeutic drugs and companies involved Functional Dyspepsia Pipeline candidates across various development ...
August 2018
30 pages
Gallbladder Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GALLBLADDER CANCER PIPELINE REPORT INCLUDES Panorama of Gallbladder Cancer pipeline markets including statistics on therapeutic drugs and companies involved Gallbladder Cancer Pipeline candidates across various development ...
August 2018
160 pages
Gastric Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GASTRIC ULCERS PIPELINE REPORT INCLUDES Panorama of Gastric Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Gastric Ulcers Pipeline candidates across various development ...
August 2018
40 pages
Gastritis (stomach inflammation) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GASTRITIS (STOMACH INFLAMMATION) PIPELINE REPORT INCLUDES Panorama of Gastritis (stomach inflammation) pipeline markets including statistics on therapeutic drugs and companies involved Gastritis (stomach inflammation) Pipeline candidates across various development ...
August 2018
40 pages
Gastroenteritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF GASTROENTERITIS PIPELINE REPORT INCLUDES Panorama of Gastroenteritis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Gaucher Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GAUCHER DISEASE PIPELINE REPORT INCLUDES Panorama of Gaucher Disease pipeline markets including statistics on therapeutic drugs and companies involved Gaucher Disease Pipeline candidates across various development ...
August 2018
50 pages
Gaucher Disease Type III R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF GAUCHER DISEASE TYPE III PIPELINE REPORT INCLUDES Panorama of Gaucher Disease Type III pipeline markets including statistics on therapeutic drugs and companies involved Gaucher Disease Type III Pipeline candidates across ...
August 2018
30 pages
Genital Herpes R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GENITAL HERPES PIPELINE REPORT INCLUDES Panorama of Genital Herpes pipeline markets including statistics on therapeutic drugs and companies involved Genital Herpes Pipeline candidates across various development ...
August 2018
70 pages
Gingivitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF GINGIVITIS PIPELINE REPORT INCLUDES Panorama of Gingivitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Gliosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF GLIOSARCOMA PIPELINE REPORT INCLUDES Panorama of Gliosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
210 pages
Globoid Cell Leukodystrophy (Krabbe Disease) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF GLOBOID CELL LEUKODYSTROPHY (KRABBE DISEASE) PIPELINE REPORT INCLUDES Panorama of Globoid Cell Leukodystrophy (Krabbe Disease) pipeline markets including statistics on therapeutic drugs and companies involved Globoid Cell Leukodystrophy (Krabbe Disease) Pipeline candidates across ...
August 2018
40 pages
Gonorrhea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF GONORRHEA PIPELINE REPORT INCLUDES Panorama of Gonorrhea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Gorlin Syndrome (Basal Cell Nevus Syndrome) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF GORLIN SYNDROME (BASAL CELL NEVUS SYNDROME) PIPELINE REPORT INCLUDES Panorama of Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline markets including statistics on therapeutic drugs and companies involved Gorlin Syndrome (Basal Cell Nevus Syndrome) Pipeline candidates across ...
August 2018
30 pages
Gouty Arthritis (Gout) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GOUTY ARTHRITIS (GOUT) PIPELINE REPORT INCLUDES Panorama of Gouty Arthritis (Gout) pipeline markets including statistics on therapeutic drugs and companies involved Gouty Arthritis (Gout) Pipeline candidates across various development ...
August 2018
80 pages
Grass Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GRASS POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Grass Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Grass Pollen Allergy Pipeline candidates across various development ...
August 2018
50 pages
Graves Diseases R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GRAVES DISEASES PIPELINE REPORT INCLUDES Panorama of Graves Diseases pipeline markets including statistics on therapeutic drugs and companies involved Graves Diseases Pipeline candidates across various development ...
August 2018
30 pages
Graves' Ophthalmopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GRAVES' OPHTHALMOPATHY PIPELINE REPORT INCLUDES Panorama of Graves' Ophthalmopathy pipeline markets including statistics on therapeutic drugs and companies involved Graves' Ophthalmopathy Pipeline candidates across various development ...
August 2018
30 pages
Guillain Barre Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GUILLAIN BARRE SYNDROME PIPELINE REPORT INCLUDES Panorama of Guillain Barre Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Guillain Barre Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Haemophilus influenzae Type B Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS PIPELINE REPORT INCLUDES Panorama of Haemophilus influenzae Type B Infections pipeline markets including statistics on therapeutic drugs and companies involved Haemophilus influenzae Type B Infections Pipeline candidates across ...
August 2018
50 pages
Hairy Cell Leukemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HAIRY CELL LEUKEMIA PIPELINE REPORT INCLUDES Panorama of Hairy Cell Leukemia pipeline markets including statistics on therapeutic drugs and companies involved Hairy Cell Leukemia Pipeline candidates across various development ...
August 2018
70 pages
